FTNTMEDIUM SIGNALFINANCIAL10-K

FTNT shows solid double-digit growth across key metrics while managing supply chain risks and transitioning from pandemic-era inventory buildups to normalized operations.

The company delivered consistent mid-teens growth in revenue, operating income, and cash flow, indicating healthy operational momentum. However, management is signaling more cautious expectations going forward, emphasizing potential headwinds from competitive dynamics, customer demand variability, and the normalization of supply chain conditions that previously boosted growth rates.

Comparing 2026-02-25 vs 2025-02-21View on EDGAR →
FINANCIAL ANALYSIS

FTNT demonstrated strong financial performance with revenue growing 14.2% to $6.8B, operating income expanding 15.6% to $2.1B, and operating cash flow increasing 14.7% to $2.6B. The balance sheet shows mixed signals with inventory up 26.6% and current liabilities rising 24%, while cash declined 13.2% and stockholders' equity decreased 17.2%. The inventory build and liability increase likely reflect ongoing supply chain management strategies, though the cash reduction and equity decline warrant monitoring.

FINANCIAL STATEMENT CHANGES
Inventory
Balance Sheet
+26.6%
$315.5M→$399.5M

Inventory built 26.6% — monitor whether demand supports this build or if write-downs may follow.

Current Liabilities
Balance Sheet
+24%
$4.1B→$5.0B

Current liabilities rose 24% — increased short-term obligations, watch current ratio.

Stockholders Equity
Balance Sheet
-17.2%
$1.5B→$1.2B

Equity decreased 17.2% — buybacks or losses reducing book value, monitor solvency ratios.

Operating Income
P&L
+15.6%
$1.8B→$2.1B

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

Accounts Receivable
Balance Sheet
+15.6%
$1.5B→$1.7B

Receivables grew 15.6% — monitor days sales outstanding for collection efficiency.

Operating Cash Flow
Cash Flow
+14.7%
$2.3B→$2.6B

Operating cash flow grew 14.7% — strong conversion of earnings to cash, healthy business fundamentals.

Revenue
P&L
+14.2%
$6.0B→$6.8B

Revenue growing 14.2% — solid top-line momentum, watch margins for quality of growth.

Gross Profit
P&L
+14%
$4.8B→$5.5B

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

R&D Expense
P&L
+13.8%
$716.8M→$815.5M

R&D investment increased 13.8% — signals commitment to future product development, though near-term margin impact.

Cash & Equivalents
Balance Sheet
-13.2%
$2.9B→$2.5B

Cash decreased 13.2% — monitor burn rate and upcoming capital needs.

LANGUAGE CHANGES
NEW — 2026-02-25
PRIOR — 2025-02-21
ADDED
As of February 20, 2026, there were 739,923,583 shares of the registrant s common stock outstanding.
During prior periods of supply chain disruption, including during the COVID-19 pandemic, we increased our purchase order commitments.
Similar conditions could arise in the future, which may require us to accept or pay for components and finished goods regardless of our level of sales in a particular period, which may negatively or unpredictably impact our operating results and financial condition.
Our billings, revenue and free cash flow growth, including our product and service billings and revenue, may slow, and our operating margins may decline, particularly if our billings and revenue do not improve or grow as anticipated, or if customer demand, renewal rates, pricing, competitive dynamics, implementation timing, cost structure, or macroeconomic conditions adversely affect our business, which could negatively impact our financial condition and results of operations.
Any weakness in sales strategy, productivity, personnel, hiring and retention, and execution could negatively impact our results of operations.
+7 more — sign up free →
REMOVED
As of February 18, 2025, there were 768,974,062 shares of the registrant s common stock outstanding.
As a result of supply chain disruptions in previous periods, we increased our purchase order commitments in previous periods and, were in some instances required to and may in the future be required to accept or pay for components and finished goods regardless of our level of sales in a particular period, which may negatively or unpredictably impact our operating results and financial condition.
Our billings, revenue, and free cash flow growth may slow or may not continue to grow, and our operating margins may decline.
As the supply chain challenges normalize, our product revenue growth rate may be lower versus prior quarters where delivery from backlog contributed more to billings.
For the fiscal year 2024, the comparably lower backlog contribution to billings resulted in decreased year-over-year quarterly growth rates.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →